J&J settles $5.5bn talc cancer lawsuits, ending decade-long litigation

For more than a decade, tens of thousands of people who believed a familiar household product had harmed them stood in legal contest against one of the world's largest pharmaceutical companies. Now, Johnson & Johnson has agreed to pay $5.5 billion to resolve nearly 70,000 lawsuits alleging its talc-based products caused ovarian cancer — a settlement that offers compensation to plaintiffs and operational closure to the company, even as the deeper question of culpability remains, by J&J's own insistence, unanswered. It is a resolution born not of admission, but of calculation — the kind of endin